Benzodiazepines and Catatonia
To the Editor: We read with interest the recent overview on "Benzodlazepines and Catatonia" by Menza and Harris (26: 842-846, i989) . The authors noted that benzodiazepines have an anticholiner~c eftect (Sca~on and Bartholini, 1982) , which may be relevant to their utility in the treatment of catato~a. In an effort to evaluate this conclusion, we studied the effect of benztropine in the ~,eatment of catatonic symptoms in an otherwise medication-free patient with a diagnosis of schizoaffective disorder.
The patient w~ a 55-year-old woman with a 36-year history of episodes of psychosis and depression, separately and in co:~bination. Past treatments included neuroleptic me:.ication and electroconvulsive therapy. She had functioned well for 5 ye.~-z ~r~ a low dose of ',hiothixene until 8 months prior to admission. Her behavior then became erratic, her speech at times illogical, and her mood labile. After stopping her medication 3 months priox" ~o adm~.bsion, her functioning declined substantially, and she was fired from three jobs.
When her neighbors noticed all of her furnitme on her lawn, the pofice were calleA and found the patient sitting on her basement stairs, mute and unresponsive. She was admitted soon after.
On examination, she was immobile except for oc-• .~o;,.,,oU,, .,eposifioning her legs. She intermittently ~, ~.~,aa~O~ squeezed the examiner's hand, and looked to~'~,srd the physician on command. Physical and neurological examinations were normal, although she offered occasional resistance. She tightly closed her eyes and clenched her jaws when examination ef eyes and mouth was attempted. If so positioned, she would remain seated or stranding for several second~, but would ~adually return to supine posture. She focused on her •mage in a band-held mircor ~f held in front of her.
Laboratory work revealed a decreased potassium level (3.2 mEq/liter), but all other studies were tinremarkable includ~.g complete blood count, urinal.-ysis, drug screen, FTA, VDRL, arterial blood gases, thyroid function tests, sedimentation rate, electrocardiogram, chest radiogram, and computed tom.ography of the head without contrast.
The initial impression was that she was catatonic.
To assess the effects of an anticholinergic agent, wc administered, in an open design, an intramuscular injection of 2 mg of benztropine. ~nitially, thi~ was without effect. Two hours later we repeated the same dosage immediatc, ly after which she said, '~Fnank you." She gradually became more alert and communicative ~om that point, responded to questions appropriately 0irst with nods of the head, then verb~y), and began eating and drin~g. She was very suspicious of the staff and not f~y cooperative with questioning or further laboratory work, but all this improved over the following days. She admitted she had been mildly depressed recently over the loss of employment, and that not taking her medication h~i been a mistake. For the remainder of her hospitalization she was remarkably pleasant although s,~new~at evasive, but fully cooperative. Thiothixene was resumed, and lithium carbonate w~s added p~rophylactically. The catatonia did not recur, her susp;.cionsness resolved for the most part, and she was discharged in good condition 4 weeks after a~mission. The rapid improvement in catatonic symptoms observed in our patient following the injection of an anticholinergic age~t is consistent with Menza and Harris' conclusion that the anticholinergic activity of benzodiazepines may be relevant to their utility in the treatment of cat~tonic symptoms. Furthermore, Kanofsky et al. (1987) have suggested that the negative syndrome may represent an attenuated form of the catatonic syndro~e., .'r~n~on and Greden 0989) have implicated ~ncreased muscarinic activity as a possible mechanism ~ the production of negative schizophrenic ~ymptoms. Interpretation must oe lunit~ because of the open, uncontrolled design, but our finding of a dramatic improvement in catatonic symptoms in a schi~affective patient foilowing benzu¢~ne would be consistent with this association. The e~ility of anti,'~holinergic agents in the treatment of catatonic symptoms aee~ to be systematically evaluated.
Response
To the Editor: This c~e report is interesting ;ram both pract~a~ ~d theoretical perspectives. We are unawme of any previous reports of such a response of c~tonic symptoms to an antieholinerg;.~ agent and, insofar as her response can be ~t!l"ibut£d to bertztropine, we agree that this me~y be of some clinical ~;mportance and sho~id be stadied more carefully.
We spec~dated in our paper that the usefulness of low-dose be:~zodiazepines in decreased dopaminergic rigid/catatonic states such as neuroleptic-induced catatonia and neuroleptic malignant syndrome may lie in, their anticholinergic effects. The patient described here appears to have a more typical "psychogenic" catatonia and perhaps the anticholinergic effec~ of low-dose benzodiazepines also oper~,.*e in some of these cases. Tendon and Greden (1989) have suggested ~i~. the negative symptoms of schizopl'trenia may result from ~ cho!,~nergic/dopaminergic imbalance analogous ~o ~st seen in parkinsonian movement disorders. If, as Kanofsky et al. (1987) suggest, there ig a relationship between negative symptoms and catatonia, then we might view catatonia more broadly ~os ~ dopaminergic/cholinergi¢ imbalance. This case report is supportive of such a model. However, as pointed out in our paper, Pfeiffer ead Jenney (1957) describe schizophrenic patients who had "lucid intervals" which included marked increases in both motor and verbal behavior in response to muscarinic cholinergic agenLs. Interestingly, not all patients improved; some developed sobbing a~d apprehension a,,~' , they did with amobarbital. These responses would not seem to be consistent with a cholinergic hyl~e.ractivity model.
Ca~atonia is etiologically a heterogeneous illness and it ts not swq~.nsmg that different treatments work i~', ¢lgfferent case:;. We look forward to further elucidati,~ of the," r~,le of antiehnlinergic agents. 
